Michael Schuler - Board of Advisors


Mike Schuler has been in the medical device industry for over 40 years. In addition to his work as the Founder and Partner of Tri-Medics, Mr. Schuler is the VP of New Business Development at the Musculoskeletal Transplant Foundation at MTF where he has served since 2002. Prior to MTF, Mike was an independent planning and new business development with major assignments including Olympus, Vidar, PNavel, HET and others. He served as Imagyn Medical Technologies as President Surgical Division, where he successfully consolidated 3 divisions. Mr. Schuler spent his first professional 18 years with Johnson and Johnson, we progressively held positions of increasing responsibility. He lead the assessment of the Palmax-Schatz Stent, helping the company acquire the breakthrough technology, and later, as Head of Marketing, was responsible for the launch of the first intravascular stent. Mr. Schuler remains active with his Alma Mater, Rutgers University, where he serves on various Industry Advisory Committees.

​​​
Copyright © Additive Orthopaedics. All Rights Reserved. All contents of this site (including artwork, text, photos, other representations of the artworks, materials related to the artworks) are protected by copyright – any use of these materials without the express permission of Additive Orthopaedics is a violation of said copyrights.

Tony Dimun- Board of Advisors


Tony Dimun brings over 30 years of highly successful operational, business development, and financial experience in the healthcare marketplace. Since 2001, he has served as Chairman of Nascent Enterprises, LLC, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, he served as Executive Vice president & Chief Financial Officer of Vital Signs, Inc., a publicly held anesthesia, respiratory and sleep apnea medical device business, providing growth strategies to enhance the Company’s value through highly focused bolt on acquisitions. Vital Signs was sold to GE Medical in 2008 for $900 million.

During the last 20 years he has been an investor and mentor to several emerging growth medical enterprises that have matured to commercial status and became publicly traded companies, acting either as the Founder or participating in the finding of 21 medical device companies. Of these enterprises, four became public companies and eight were sold. Mr. Dimun has been a director of several public companies, including, Vital Signs, Inc., Bionx Implants, Inc., Colorado MedTech Inc., Photomedix, ISS Surgical Systems and numerous privately held companies in the healthcare industry. He also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and through Nascent Enterprises provides the University of Pennsylvania with entrepreneurial assistance to commercialize Penn’s medical technology. Prior to 1991, Mr. Dimun held positions as a Certified Public Accountant with national accounting firms and served as Senior VP for an international merchant banking firm specializing in mergers & acquisitions.

Dr. Selene Parekh - Board of Advisors


Dr. Parekh joined the North Carolina Orthopaedic Clinic and Duke Orthopaedics in 2009, where he is a Professor of Surgery in the Department of Orthopaedic Surgery. Prior to his tenure at Duke, Dr. Parekh was a Foot and Ankle Surgeon at the University of North Carolina (UNC). While there, he was integrally involved in the teaching of medical students and residents. Furthermore, he served as the foot and ankle consultant to the Athletic Department, treating many of the well-known UNC athletes. In his current practice, he continues to treat competitive athletes of all levels. A graduate of the Boston University School of Medicine, Dr. Parekh completed his internship and residency at the Hospital of the University of Pennsylvania and his fellowship in foot and ankle surgery under the direction of some of the leading global authorities at the University of Pennsylvania.

Our Story

Brian McLaughlin, VP Engineering


Brian McLaughlin has over 15 years of a blended background ranging from new product development, engineering, business development, sales and marketing. For the past 8 years, he has been heavily involved in orthopaedics from different aspects of the industry including orthopaedic specific product development for Orchid Design, OEM sales for upper and lower extremity products as an Independent Orthopaedic Sales Rep, and most recently as the Additive Manufacturing Business Unit Manager for DiSanto Technology, an Arcam company. He holds a BS in Biomedical Engineering from the University of Vermont with a focus on Orthopaedics.

The goal of Additive Orthopaedics is the integration of advanced manufacturing and biologics for the benefit of a better patient outcome. The company is laser focused on leveraging the patient, technological and cost benefits of additive manufacturing into the global orthopaedics market.

Additive Manufacturing allows us to develop advanced orthopaedic devices, with complex geometries, never before possible with older, subtractive manufacturing processes; at lower costs of goods sold. These devices can also be customized for individual patients.

Greg Kowalczyk, President


Greg Kowalczyk has been involved in orthopaedic product development, marketing, business development and sales for over 20 years for companies such as Aircast, Stryker, Integra, the Prodigy Group, and MTF. Most recently, he functioned as the Vice President of Marketing and Interim CEO for Nextremity Solutions. He also founded co-founded Proception Medical, an orthopaedic medical device incubatory company. He holds a BS in Mechanical Engineering from Lehigh University and a MS in Biomedical Engineering from NJIT.